Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond

References

• Sikuler E, Groszmann RJ. Interaction of flow and resistance in maintenance of portal hypertension in a rat model. Am J Physiol. 1986;250:G205–G212.
   PubMed Web of Science ®Google Scholar
• Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol. 1985;1:325–327.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–1761.
   PubMed Web of Science ®Google Scholar
• Berzigotti A, Seijo S, Reverter E. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141–155.
   PubMed Web of Science ®Google Scholar
• Simón-Talero M, Roccarina D, Martínez J, et al. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology. 2018;154:1694–1705.
   PubMed Web of Science ®Google Scholar
• Paton A, Reynolds TB, Sherlock S. Assessment of portal venous hypertension by catheterisation of hepatic vein. Lancet. 1953;1:918–921.
   PubMed Web of Science ®Google Scholar
• Armonis A, Patch D, Burroughs A. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis? Hepatology. 1997;25:245–248.
   PubMed Web of Science ®Google Scholar
• Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99:1401–1407.
   PubMed Web of Science ®Google Scholar
• Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–2261.
   PubMed Web of Science ®Google Scholar
• Casado M, Bosch J, Garcia PJC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296–1303.
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–424.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–488.
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases. Hepatology. 2017;65:310–335.
   PubMed Web of Science ®Google Scholar
• Viallet A, Marleau D, Huet M, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975;69:1297–1300.
   PubMed Web of Science ®Google Scholar
• Vinel JP, Cassigneul J, Levade M, et al. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 1986;6:116–117.
   PubMed Web of Science ®Google Scholar
• Ready JB, Robertson AD, Goff JS, et al. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991;100:1403–1410.
   PubMed Web of Science ®Google Scholar
• Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626–631.
   PubMed Web of Science ®Google Scholar
• Vorobioff J, Groszmann RJ, Picabea E, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology. 1996;111:701–709.
   PubMed Web of Science ®Google Scholar
• Villanueva C, Albillos A, Genesca J, et al. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016;63:197–206.
   PubMed Web of Science ®Google Scholar
• Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–1059.
   PubMed Web of Science ®Google Scholar
• Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930–934.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Garcia-Pagan JC, Luca A, et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611–1624.
   PubMed Web of Science ®Google Scholar
• Villanueva C, Aracil C, Colomo A, et al. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology. 2009;137:119–128.
   PubMed Web of Science ®Google Scholar
• Turnes JC, Garcia-Pagan J, Abraldes M, et al. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterology. 2006;101:506–507.
   PubMed Web of Science ®Google Scholar
• Merkel C, Bolognesi M, Berzigotti A, et al. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol. 2010;52:45–53.
   PubMed Web of Science ®Google Scholar
• McCormick PA, Patch D, Greenslade L, et al. Clinical vs haemodynamic response to drugs in portal hypertension. J Hepatol. 1998;28:1015–1019.
   PubMed Web of Science ®Google Scholar
• Villanueva C, Graupera I, Aracil C, et al. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology. 2017;65:1693–1707.
   PubMed Web of Science ®Google Scholar
• Reiberger T, Ulbrich J, Ferlitsch A, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013;62:1634–1641.
   PubMed Web of Science ®Google Scholar
• Kim SG, Kim TY, Sohn JH, et al. A randomized, multi-center, open-label study to evaluate the efficacy of carvedilol vs. propranolol to reduce portal pressure in patients with liver cirrhosis. Am J Gastroenterol. 2016;111:1582–1590.
   PubMed Web of Science ®Google Scholar
• Li T, Ke W, Sun P, et al. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis. BMJ Open. 2016;6:e010902.
   PubMed Web of Science ®Google Scholar
• Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 1988;8:222–227.
   PubMed Web of Science ®Google Scholar
• Merkel C, Bolognesi M, Bellon S, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992;102:973–979.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Banares R, Rincon D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005;42:793–801.
   PubMed Web of Science ®Google Scholar
• Zipprich A, Garcia-Tsao G, Rogowski S, et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407–1414.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Groszmann RJ, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50:923–928.
   PubMed Web of Science ®Google Scholar
• Suk KT, Kim EJ, Kim DJ, et al. Prognostic significance of hemodynamic and clinical stages in the prediction of hepatocellular carcinoma. J Clin Gastroenterol. 2017;51:285–293.
   PubMed Web of Science ®Google Scholar
• Kim MY, Baik SK, Yea CJ, et al. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Eur J Gastroenterol Hepatol. 2009;21:1241–1246.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–1440.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–1916.
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Cescon M, Golfieri R, et al. Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma. J Hepatol. 2016;64:79–86.
   PubMed Web of Science ®Google Scholar
• Poynard T, Munteanu M, Deckmyn O, et al. Applicability and precautions of use of liver injury biomarker fibrotest. A reappraisal at 7 years of age. BMC Gastroenterol. 2011;11:39.
   PubMed Web of Science ®Google Scholar
• Imbert-Bismut F, Messous D, Thibaut V, et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med. 2004;42:323–333.
   PubMed Web of Science ®Google Scholar
• Cales P, Veillon P, Konate A, et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem. 2008;41:10–18.
   PubMed Web of Science ®Google Scholar
• Castera L, Chan HL, Arrese M, et al. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.J Hepatol.2015;63:237–264.
   PubMed Web of Science ®Google Scholar
• Giannini E, Risso D, Botta F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med. 2003;163:2804–2824.
   Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–526.
   PubMed Web of Science ®Google Scholar
• Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350.
   PubMed Web of Science ®Google Scholar
• Castera L, Le Bail B, Roudot-Thoraval F, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol. 2009;50:59–68.
   PubMed Web of Science ®Google Scholar
• Thabut D, Trabut JB, Massard J, et al. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int. 2006;26:271–278.
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010;53:630–638.
   PubMed Web of Science ®Google Scholar
• Deng H, Qi X, Guo X. Diagnostic accuracy of APRI, AAR, FIB-4, FI, king, lok, forns, and fibroindex scores in predicting the presence of esophageal varices in liver cirrhosis: a systematic review and meta-analysis. Medicine. 2015;94:e1795.
   PubMed Web of Science ®Google Scholar
• Berzigotti A, Gilabert R, Abraldes JG, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol. 2008;103:1159–1167.
   PubMed Web of Science ®Google Scholar
• Moriyasu F, Nishida O, Ban N, et al. Measurement of portal vascular resistance in patients with portal hypertension. Gastroenterology. 1986;90:710–717.
   PubMed Web of Science ®Google Scholar
• Cioni G, D'Alimonte P, Zerbinati F, et al. Duplex-doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs. J Gastroenterol Hepatol. 1992;7:388–392.
   PubMed Web of Science ®Google Scholar
• Zironi G, Gaiani S, Fenyves D, et al. Value of measurement of mean portal flow velocity by doppler flowmetry in the diagnosis of portal hypertension. J Hepatol. 1992;16:298–303.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Baik SK, Park DH, et al. Comparison of doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol. 2003;18:424–429.
   PubMed Web of Science ®Google Scholar
• Bolondi L, Li Bassi S, Gaiani S, et al. Liver cirrhosis: changes of doppler waveform of hepatic veins. Radiology. 1991;178:513–516.
   PubMed Web of Science ®Google Scholar
• Ohta M, Hashizume M, Tomikawa M, et al. Analysis of hepatic vein waveform by DOPPLER ultrasonography in 100 patients with portal hypertension. Am J Gastroenterol. 1994;89:170–175.
   PubMed Web of Science ®Google Scholar
• Baik SK, Kim JW, Kim HS, et al. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006;240:574–580.
   PubMed Web of Science ®Google Scholar
• Kim MY, Baik SK, Park DH, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int. 2007;27:1103–1110.
   PubMed Web of Science ®Google Scholar
• Albrecht T, Blomley MJ, Cosgrove DO, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 1999;353:1579–1583.
   PubMed Web of Science ®Google Scholar
• Maleux G, Willems E, Fieuws S, et al. Prospective study comparing different indirect methods to measure portal pressure. J Vasc Interv Radiol. 2011;22:1553–1558.
   PubMed Web of Science ®Google Scholar
• Sato T, Yamazaki K, Toyota J, et al. Color Doppler findings of gastric varices compared with findings on computed tomography. J Gastroenterol. 2002;37:604–610.
   PubMed Web of Science ®Google Scholar
• Jeong WK, Kim TY, Sohn JH, et al. Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography. PLoS One. 2015;10:e0121601.
   PubMed Web of Science ®Google Scholar
• Shimada T, Maruyama H, Kondo T, et al. Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics. Eur Radiol. 2015;25:812–820.
   PubMed Web of Science ®Google Scholar
• Carrion JA, Navasa M, Bosch J, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12:1791–1799.
   PubMed Web of Science ®Google Scholar
• Bolognesi M, Di Pascoli M, Sacerdoti D, et al. Clinical role of non-invasive assessment of portal hypertension. World J Gastroenterol. 2017;23:1–10.
   PubMed Web of Science ®Google Scholar
• Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012;56:696–703.
   PubMed Web of Science ®Google Scholar
• Lemoine M, Katsahian S, Ziol M, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther. 2008;28:1102–1110.
   PubMed Web of Science ®Google Scholar
• Cho EJ, Kim MY, Lee JH, et al. Diagnostic and prognostic values of noninvasive predictors of portal hypertension in patients with alcoholic cirrhosis. PLoS One. 2015;10:e0133935.
   PubMed Web of Science ®Google Scholar
• Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408.
   PubMed Web of Science ®Google Scholar
• Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45:1290–1297.
   PubMed Web of Science ®Google Scholar
• Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27:1261–1268.
   PubMed Web of Science ®Google Scholar
• Kumar A, Khan NM, Anikhindi SA, et al. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India. Wjg. 2017;23:687–696.
   PubMed Web of Science ®Google Scholar
• Reiberger T, Ferlitsch A, Payer BA, et al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography–a large single center experience. Wien Klin Wochenschr. 2012;124:395–402.
   PubMed Web of Science ®Google Scholar
• Robic MA, Procopet B, Metivier S, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55:1017–1024.
   PubMed Web of Science ®Google Scholar
• Kitson MT, Roberts SK, Colman JC, et al. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scand J Gastroenterol. 2015;50:462–469.
   PubMed Web of Science ®Google Scholar
• Procopet B, Berzigotti A, Abraldes JG, et al. Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. J Hepatol. 2015;62:1068–1075.
   PubMed Web of Science ®Google Scholar
• Elkrief L, Rautou PE, Ronot M, et al. Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology 2015;275:589–598.
   PubMed Web of Science ®Google Scholar
• Kim TY, Jeong WK, Sohn JH, et al. Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients. Liver Int. 2015;35:2416–2424.
   PubMed Web of Science ®Google Scholar
• Shi KQ, Fan YC, Pan ZZ, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33:62–71.
   PubMed Web of Science ®Google Scholar
• Pu K, Shi JH, Wang X, et al. Diagnostic accuracy of transient elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: A meta-analysis. Wjg. 2017;23:345–356.
   PubMed Web of Science ®Google Scholar
• Li T, Qu Y, Yang B, et al. Evaluation of large esophageal varices in cirrhotic patients by transient elastography: a meta-analysis. Rev Esp Enferm Dig. 2016;108:464–472.
   PubMed Web of Science ®Google Scholar
• Qu Y, Li T, Ye Q, et al. A beginning or the end? a meta-analysis to assess the diagnostic accuracy of transient elastography for the prediction of esophageal varices. Saudi J Gastroenterol. 2016;22:345–352.
   PubMed Web of Science ®Google Scholar
• de Franchis R. Expanding consensus in portal hypertension: report of the baveno vi consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
   PubMed Web of Science ®Google Scholar
• Tosetti G, La Mura V, Aghemo A, et al. Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: beyond the Baveno VI criteria. Dig Liv Dis. 2017;49:e38.
   Web of Science ®Google Scholar
• Llop E, Lopez M, de la Revilla J, et al. Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease. J Gastroenterol. Hepatol. 2017;32:1867–1872.
   PubMed Web of Science ®Google Scholar
• Maurice JB, Brodkin E, Arnold F, et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol. 2016;65:899–905.
   PubMed Web of Science ®Google Scholar
• Marot A, Trepo E, Doerig C, et al. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk for variceal bleeding. Liver Int. 2017;37:707–716.
   PubMed Web of Science ®Google Scholar
• Abraldes JG, Bureau C, Stefanescu H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “anticipate” study. Hepatology. 2016;64:2173–2184.
   PubMed Web of Science ®Google Scholar
• Augustin S, Pons M, Maurice JB, et al. Expanding Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66:1980–1988.
   PubMed Web of Science ®Google Scholar
• Castera L, Garcia-Tsao G. When the spleen gets tough, the varices get going. Gastroenterology. 2013;144:19–22.
   PubMed Web of Science ®Google Scholar
• Giunta M, Conte D, Fraquelli M. Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol. 2016;22:7857–7867.
   PubMed Web of Science ®Google Scholar
• Hirooka M, Ochi H, Koizumi Y, et al. Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension. Radiology. 2011;261:960–968.
   PubMed Web of Science ®Google Scholar
• Song J, Huang J, Huang H, et al. Performance of spleen stiffness measurement in prediction of clinical significant portal hypertension: a meta-analysis. Clin Res Hepatol Gastroenterol. 2018;42:216–226.
   Google Scholar
• Stefanescu H, Grigorescu M, Lupsor M, et al. Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol. 2011;26:164–170.
   PubMed Web of Science ®Google Scholar
• Fraquelli M, Giunta M, Pozzi R, et al. Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis. J Viral Hepat. 2014;21:90–98.
   PubMed Web of Science ®Google Scholar
• Sharma P, Kirnake V, Tyagi P, et al. Spleen stiffness in patients with cirrhosis in predicting esophageal varices. Am J Gastroenterol. 2013;108:1101–1107.
   PubMed Web of Science ®Google Scholar
• Takuma Y, Nouso K, Morimoto Y, et al. Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology. 2013;144:92–101.e2.
   PubMed Web of Science ®Google Scholar
• Singh S, Eaton JE, Murad MH, et al. Accuracy of spleen stiffness measurement in detection of esophageal varices in patients with chronic liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:935–945.e4.
   PubMed Web of Science ®Google Scholar
• Ma X, Wang L, Wu H, et al. Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis. PLoS One. 2016;11:e0165786.
   PubMed Web of Science ®Google Scholar
• Buechter M, Manka P, Theysohn JM, et al. Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis. 2018;50:54–60.
   PubMedGoogle Scholar
• Gao J, Ran HT, Ye XP, et al. The stiffness of the liver and spleen on ARFI imaging pre and post TIPS placement: a preliminary observation. Clin Imaging. 2012;36:135–141.
   PubMed Web of Science ®Google Scholar
• Guo J, Buning C, Schott E, et al. In vivo abdominal magnetic resonance elastography for the assessment of portal hypertension before and after transjugular intrahepatic portosystemic shunt implantation. Invest Radiol. 2015;50:347–351.
   PubMed Web of Science ®Google Scholar
• Novelli PM, Cho K, Rubin JM. Sonographic assessment of spleen stiffness before and after transjugular intrahepatic portosystemic shunt placement with or without concurrent embolization of portal systemic collateral veins in patients with cirrhosis and portal hypertension: a feasibility study. J Ultrasound Med. 2015;34:443–449.
   PubMed Web of Science ®Google Scholar
• Jansen C, Bogs C, Verlinden W, et al. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: a prospective multicentre study. Liver Int. 2017;37:396–405.
   PubMed Web of Science ®Google Scholar
• Elkrief L, Ronot M, Andrade F, et al. Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther. 2018;47:621–630.
   PubMed Web of Science ®Google Scholar
• Colecchia A, Colli A, Casazza G, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. J Hepatol. 2014;60:1158–1164.
   PubMed Web of Science ®Google Scholar
• Buechter M, Kahraman A, Manka P, et al. Spleen and liver stiffness is positively correlated with the risk of esophageal variceal bleeding. Digestion. 2016;94:138–144.
   PubMed Web of Science ®Google Scholar
• Guo YL, Lu XL, Cheng Y, et al. Combination measurement of liver and spleen stiffness with portal vein width to evaluate risk of bleeding in esophageal and gastric varices patients. Chinese J Hepatol. 2016;24:56–61.
   PubMedGoogle Scholar
• Wong GLH, Kwok R, Hui AJ, et al. A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial. Liver Int. 2018;38:636–644.
   PubMed Web of Science ®Google Scholar